Corona vaccine: In the third trial conducted in Britain, Novavax has shown an effective 89.3% against Kovid 19. This trial was done on more than 15 thousand people between 18 and 84 years.
New Delhi. A new Corona Vaccine has been developed in Britain to defeat the Coronavirus. In the UK trial, this vaccine called Novavax has been found to be 89.3 percent effective against Covid 19. At the same time, British scientists claim that this vaccine is also effective against the new form of corona virus found in Britain. In such a situation, after the vaccine, Kovid has raised another hope against the 19 pandemic.
The British government says that if it gets the green signal from the Medicines and Healthcare Products Regulatory Agency, Novavax vaccine will be available to people by the middle of this year. Earlier, three corona vaccines have been approved in the UK at present. These include Oxford University and AstraZeneca’s Vaccine, Pfizer and Bioentech’s Vaccine and Mordana’s Vaccine.
Jammu and Kashmir: Terrorist attack on army’s road opening party in Anantnag, 3 soldiers injured
It has been reported that in the third trial conducted in Britain, Novavax has shown an effective 89.3% against Kovid 19. This trial was done on more than 15 thousand people between 18 and 84 years. Of these, 27 percent were over 65 years of age. The good news about this is that this vaccine has also been found to be 60% effective on the new form of corona found in South Africa.
A top official associated with Novavax says that the trial of this vaccine in Britain has given unprecedented results. This is in line with our expectations. According to Professor Paul Heath, the Chief Investigator of the Novavax trial in Britain, this is highly appreciated. This shows that it is a very safe and effective corona vaccine. In particular, it has also been found effective on the new Corona virus form of Britain.
